X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
0
Europe
Canada
0
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2023-80553.pdf
https://www.raps.org/news-and-articles/news-articles/2019/5/generic-drugmaker-admits-to-price-fixing
https://www.propublica.org/article/when-a-study-cast-doubt-on-heart-pill-the-drug-company-turned-to-tom-price
http://www.forbes.com/sites/brucejapsen/2016/10/12/these-10-drugs-are-busting-hospital-budgets/#4ae9da803d29
http://www.prnewswire.com/news-releases/mylan-launches-generic-apresoline-injection-300263099.html
https://www.pharmacompass.com/pdf/news/x-gens-generic-hydralazine-hcl-20mgml-approved-in-us-for-hypertension-1435840480.pdf
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0332-2015&w=01142015&lang=eng
Market Place
Share 
